Glenmark Pharma initiates clinical investigation for GBR 310
GBR 310 is a recombinant DNA-derived humanised immunoglobulin G1 kappa monoclonal antibody
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.